Verdoia M, Rolla R, Pergolini P, Gioscia R, et al. Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor. Catheter Cardiovasc Interv 2021;98:1309-1316.
PMID: 33527669